A phase I, randomized, placebo‐controlled trial to evaluate the pharmacokinetics, safety, and tolerability of nirsevimab in healthy Chinese adults

Ähnliche Einträge

• Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants
  von: Lindsay Clegg, et al.
  Veröffentlicht: (2024)
• A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
  von: Panpan Xie, et al.
  Veröffentlicht: (2024)
• The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
  von: Yue Liu, et al.
  Veröffentlicht: (2025)
• Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
  von: Irina Baltcheva, et al.
  Veröffentlicht: (2026)
• Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers
  von: Rong Shao, et al.
  Veröffentlicht: (2024)